nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CHRM3—nephrolithiasis	0.755	1	CbGaD
Doxepin—CHRM3—ureter—nephrolithiasis	0.00863	0.261	CbGeAlD
Doxepin—CYP2C19—urine—nephrolithiasis	0.00261	0.0789	CbGeAlD
Doxepin—CYP1A2—urine—nephrolithiasis	0.00213	0.0645	CbGeAlD
Doxepin—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0234	CcSEcCtD
Doxepin—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0229	CcSEcCtD
Doxepin—CYP2C9—urine—nephrolithiasis	0.00202	0.0612	CbGeAlD
Doxepin—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00194	0.0219	CcSEcCtD
Doxepin—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0216	CcSEcCtD
Doxepin—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00186	0.021	CcSEcCtD
Doxepin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00181	0.0204	CcSEcCtD
Doxepin—HTR2A—urine—nephrolithiasis	0.00166	0.0504	CbGeAlD
Doxepin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00165	0.0186	CcSEcCtD
Doxepin—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00163	0.0184	CcSEcCtD
Doxepin—CYP3A4—urine—nephrolithiasis	0.00154	0.0467	CbGeAlD
Doxepin—CYP2D6—urine—nephrolithiasis	0.00152	0.0459	CbGeAlD
Doxepin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00138	0.0155	CcSEcCtD
Doxepin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00136	0.0154	CcSEcCtD
Doxepin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0152	CcSEcCtD
Doxepin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0151	CcSEcCtD
Doxepin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00132	0.0148	CcSEcCtD
Doxepin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0147	CcSEcCtD
Doxepin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0146	CcSEcCtD
Doxepin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00129	0.0146	CcSEcCtD
Doxepin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00127	0.0143	CcSEcCtD
Doxepin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00122	0.0138	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00121	0.0137	CcSEcCtD
Doxepin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0012	0.0135	CcSEcCtD
Doxepin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0129	CcSEcCtD
Doxepin—ADRA1B—renal system—nephrolithiasis	0.00112	0.034	CbGeAlD
Doxepin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00111	0.0125	CcSEcCtD
Doxepin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0124	CcSEcCtD
Doxepin—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0124	CcSEcCtD
Doxepin—ADRA1B—kidney—nephrolithiasis	0.00108	0.0328	CbGeAlD
Doxepin—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0121	CcSEcCtD
Doxepin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00105	0.0119	CcSEcCtD
Doxepin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000986	0.0111	CcSEcCtD
Doxepin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00098	0.0111	CcSEcCtD
Doxepin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000974	0.011	CcSEcCtD
Doxepin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000971	0.011	CcSEcCtD
Doxepin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00096	0.0108	CcSEcCtD
Doxepin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000946	0.0107	CcSEcCtD
Doxepin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.000921	0.0104	CcSEcCtD
Doxepin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000916	0.0103	CcSEcCtD
Doxepin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000914	0.0103	CcSEcCtD
Doxepin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000901	0.0102	CcSEcCtD
Doxepin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000882	0.00995	CcSEcCtD
Doxepin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000877	0.0099	CcSEcCtD
Doxepin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000859	0.00969	CcSEcCtD
Doxepin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000844	0.00952	CcSEcCtD
Doxepin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00084	0.00947	CcSEcCtD
Doxepin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000838	0.00945	CcSEcCtD
Doxepin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000831	0.00938	CcSEcCtD
Doxepin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000787	0.00888	CcSEcCtD
Doxepin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000783	0.00884	CcSEcCtD
Doxepin—Chlorprothixene—CHRM3—nephrolithiasis	0.000774	0.172	CrCbGaD
Doxepin—Nortriptyline—CHRM3—nephrolithiasis	0.00076	0.168	CrCbGaD
Doxepin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000754	0.00851	CcSEcCtD
Doxepin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000746	0.00841	CcSEcCtD
Doxepin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000735	0.00829	CcSEcCtD
Doxepin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000724	0.00817	CcSEcCtD
Doxepin—Tension—Hydrochlorothiazide—nephrolithiasis	0.000721	0.00813	CcSEcCtD
Doxepin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000719	0.00812	CcSEcCtD
Doxepin—HTR2B—cortex of kidney—nephrolithiasis	0.000718	0.0217	CbGeAlD
Doxepin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000714	0.00805	CcSEcCtD
Doxepin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000711	0.00802	CcSEcCtD
Doxepin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00797	CcSEcCtD
Doxepin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000692	0.00781	CcSEcCtD
Doxepin—Promethazine—CHRM3—nephrolithiasis	0.000689	0.153	CrCbGaD
Doxepin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000688	0.00777	CcSEcCtD
Doxepin—CHRM3—renal system—nephrolithiasis	0.000686	0.0208	CbGeAlD
Doxepin—HTR1A—renal system—nephrolithiasis	0.000684	0.0207	CbGeAlD
Doxepin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000682	0.00769	CcSEcCtD
Doxepin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000679	0.00766	CcSEcCtD
Doxepin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000675	0.00762	CcSEcCtD
Doxepin—CHRM3—kidney—nephrolithiasis	0.000663	0.0201	CbGeAlD
Doxepin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000662	0.00747	CcSEcCtD
Doxepin—ADRA2C—nephron tubule—nephrolithiasis	0.000661	0.02	CbGeAlD
Doxepin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00066	0.00745	CcSEcCtD
Doxepin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000659	0.00743	CcSEcCtD
Doxepin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000658	0.00742	CcSEcCtD
Doxepin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000649	0.00732	CcSEcCtD
Doxepin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000646	0.00728	CcSEcCtD
Doxepin—Cough—Hydrochlorothiazide—nephrolithiasis	0.000641	0.00723	CcSEcCtD
Doxepin—ADRA1A—renal system—nephrolithiasis	0.00063	0.0191	CbGeAlD
Doxepin—Desipramine—CHRM3—nephrolithiasis	0.000626	0.139	CrCbGaD
Doxepin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00706	CcSEcCtD
Doxepin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00706	CcSEcCtD
Doxepin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00706	CcSEcCtD
Doxepin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000623	0.00703	CcSEcCtD
Doxepin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000618	0.00697	CcSEcCtD
Doxepin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000612	0.0069	CcSEcCtD
Doxepin—KCNH2—renal system—nephrolithiasis	0.000609	0.0184	CbGeAlD
Doxepin—Promazine—CHRM3—nephrolithiasis	0.000606	0.134	CrCbGaD
Doxepin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000605	0.00682	CcSEcCtD
Doxepin—ADRA2C—renal system—nephrolithiasis	0.0006	0.0182	CbGeAlD
Doxepin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0006	0.00676	CcSEcCtD
Doxepin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00059	0.00666	CcSEcCtD
Doxepin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000587	0.00662	CcSEcCtD
Doxepin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000585	0.0066	CcSEcCtD
Doxepin—ADRA2C—kidney—nephrolithiasis	0.00058	0.0176	CbGeAlD
Doxepin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00058	0.00654	CcSEcCtD
Doxepin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000572	0.00645	CcSEcCtD
Doxepin—ADRA2C—cortex of kidney—nephrolithiasis	0.000565	0.0171	CbGeAlD
Doxepin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00056	0.00632	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000546	0.00616	CcSEcCtD
Doxepin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000542	0.00612	CcSEcCtD
Doxepin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000538	0.00607	CcSEcCtD
Doxepin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000535	0.00603	CcSEcCtD
Doxepin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000533	0.00601	CcSEcCtD
Doxepin—Imipramine—CHRM3—nephrolithiasis	0.000531	0.118	CrCbGaD
Doxepin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000528	0.00595	CcSEcCtD
Doxepin—Amitriptyline—CHRM3—nephrolithiasis	0.000527	0.117	CrCbGaD
Doxepin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000521	0.00588	CcSEcCtD
Doxepin—CYP1A2—renal system—nephrolithiasis	0.000521	0.0158	CbGeAlD
Doxepin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000517	0.00583	CcSEcCtD
Doxepin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000513	0.00578	CcSEcCtD
Doxepin—Pain—Hydrochlorothiazide—nephrolithiasis	0.000513	0.00578	CcSEcCtD
Doxepin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000494	0.00557	CcSEcCtD
Doxepin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00049	0.00553	CcSEcCtD
Doxepin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000476	0.00537	CcSEcCtD
Doxepin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000474	0.00535	CcSEcCtD
Doxepin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000474	0.00535	CcSEcCtD
Doxepin—ADRA2A—cortex of kidney—nephrolithiasis	0.000451	0.0137	CbGeAlD
Doxepin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000442	0.00498	CcSEcCtD
Doxepin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00043	0.00485	CcSEcCtD
Doxepin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000424	0.00479	CcSEcCtD
Doxepin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00041	0.00463	CcSEcCtD
Doxepin—HTR2A—renal system—nephrolithiasis	0.000407	0.0123	CbGeAlD
Doxepin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000396	0.00447	CcSEcCtD
Doxepin—HTR2A—kidney—nephrolithiasis	0.000394	0.0119	CbGeAlD
Doxepin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000381	0.0043	CcSEcCtD
Doxepin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000378	0.00427	CcSEcCtD
Doxepin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000378	0.00426	CcSEcCtD
Doxepin—CYP3A4—renal system—nephrolithiasis	0.000377	0.0114	CbGeAlD
Doxepin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000376	0.00424	CcSEcCtD
Doxepin—CYP2D6—renal system—nephrolithiasis	0.000371	0.0112	CbGeAlD
Doxepin—CYP3A4—kidney—nephrolithiasis	0.000365	0.011	CbGeAlD
Doxepin—CYP2D6—kidney—nephrolithiasis	0.000359	0.0109	CbGeAlD
Doxepin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000356	0.00402	CcSEcCtD
Doxepin—ABCB1—nephron tubule—nephrolithiasis	0.000294	0.00889	CbGeAlD
Doxepin—ABCB1—renal system—nephrolithiasis	0.000267	0.00808	CbGeAlD
Doxepin—ABCB1—kidney—nephrolithiasis	0.000258	0.00781	CbGeAlD
Doxepin—ABCB1—cortex of kidney—nephrolithiasis	0.000251	0.00761	CbGeAlD
Doxepin—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	7.36e-05	0.000618	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	7.33e-05	0.000616	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	7.31e-05	0.000615	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	7.24e-05	0.000609	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	7.22e-05	0.000607	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	7.19e-05	0.000605	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	7.14e-05	0.0006	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	7.13e-05	0.000599	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	7.13e-05	0.000599	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	7.08e-05	0.000595	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	7.02e-05	0.00059	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	7e-05	0.000588	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AGXT—nephrolithiasis	6.99e-05	0.000588	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	6.96e-05	0.000585	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—GRHPR—nephrolithiasis	6.94e-05	0.000584	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—PTH—nephrolithiasis	6.92e-05	0.000582	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	6.91e-05	0.000581	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	6.89e-05	0.000579	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	6.89e-05	0.000579	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—PTH—nephrolithiasis	6.88e-05	0.000578	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	6.87e-05	0.000578	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	6.85e-05	0.000576	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	6.84e-05	0.000575	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	6.83e-05	0.000574	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	6.8e-05	0.000572	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	6.78e-05	0.00057	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	6.76e-05	0.000568	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	6.74e-05	0.000567	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	6.74e-05	0.000567	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	6.71e-05	0.000564	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	6.7e-05	0.000563	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	6.68e-05	0.000562	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	6.66e-05	0.00056	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	6.64e-05	0.000558	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	6.57e-05	0.000553	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	6.56e-05	0.000551	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	6.56e-05	0.000551	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	6.53e-05	0.000549	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	6.48e-05	0.000544	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	6.45e-05	0.000543	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	6.43e-05	0.00054	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	6.39e-05	0.000537	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—GRHPR—nephrolithiasis	6.37e-05	0.000536	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	6.35e-05	0.000534	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	6.35e-05	0.000534	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	6.32e-05	0.000531	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	6.27e-05	0.000527	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	6.25e-05	0.000526	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AGXT—nephrolithiasis	6.19e-05	0.00052	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—DGKH—nephrolithiasis	6.19e-05	0.00052	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.19e-05	0.00052	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	6.17e-05	0.000519	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	6.14e-05	0.000516	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	6.09e-05	0.000512	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	5.97e-05	0.000502	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—RGS14—nephrolithiasis	5.95e-05	0.0005	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	5.94e-05	0.0005	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—APRT—nephrolithiasis	5.94e-05	0.0005	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	5.88e-05	0.000494	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	5.88e-05	0.000494	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	5.86e-05	0.000492	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	5.85e-05	0.000491	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RGS14—nephrolithiasis	5.84e-05	0.000491	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	5.83e-05	0.00049	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.83e-05	0.00049	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—CHRM3—nephrolithiasis	5.83e-05	0.00049	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	5.82e-05	0.00049	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	5.81e-05	0.000488	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	5.8e-05	0.000488	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	5.75e-05	0.000483	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	5.73e-05	0.000482	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AGXT—nephrolithiasis	5.68e-05	0.000477	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.65e-05	0.000475	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	5.65e-05	0.000475	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	5.64e-05	0.000474	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	5.61e-05	0.000472	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	5.6e-05	0.000471	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.59e-05	0.00047	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	5.59e-05	0.00047	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	5.57e-05	0.000469	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	5.46e-05	0.000459	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	5.42e-05	0.000456	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	5.42e-05	0.000455	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	5.37e-05	0.000452	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	5.34e-05	0.000449	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—PTH—nephrolithiasis	5.33e-05	0.000448	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	5.33e-05	0.000448	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	5.33e-05	0.000448	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	5.32e-05	0.000447	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	5.31e-05	0.000446	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	5.3e-05	0.000446	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—APRT—nephrolithiasis	5.26e-05	0.000442	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—SLC26A1—nephrolithiasis	5.26e-05	0.000442	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	5.25e-05	0.000442	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.25e-05	0.000442	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	5.23e-05	0.00044	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	5.22e-05	0.000439	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	5.12e-05	0.000431	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	5.1e-05	0.000429	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	5.08e-05	0.000427	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	4.96e-05	0.000417	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	4.95e-05	0.000417	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	4.92e-05	0.000414	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	4.88e-05	0.00041	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	4.88e-05	0.00041	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	4.86e-05	0.000409	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.85e-05	0.000408	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	4.85e-05	0.000408	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	4.84e-05	0.000407	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	4.83e-05	0.000406	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	4.83e-05	0.000406	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—APRT—nephrolithiasis	4.83e-05	0.000406	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	4.83e-05	0.000406	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	4.81e-05	0.000405	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	4.79e-05	0.000402	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	4.77e-05	0.000401	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	4.75e-05	0.0004	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	4.74e-05	0.000399	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.74e-05	0.000399	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	4.74e-05	0.000398	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.58e-05	0.000385	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	4.58e-05	0.000385	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	4.55e-05	0.000383	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.55e-05	0.000383	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GRHPR—nephrolithiasis	4.51e-05	0.000379	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—PTH—nephrolithiasis	4.5e-05	0.000378	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CHRM3—nephrolithiasis	4.47e-05	0.000376	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	4.44e-05	0.000373	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	4.43e-05	0.000372	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.43e-05	0.000372	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	4.43e-05	0.000372	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—PTH—nephrolithiasis	4.42e-05	0.000371	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GRHPR—nephrolithiasis	4.41e-05	0.00037	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	4.4e-05	0.00037	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	4.4e-05	0.00037	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	4.39e-05	0.000369	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.36e-05	0.000367	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	4.36e-05	0.000367	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	4.35e-05	0.000365	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	4.34e-05	0.000364	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AQP1—nephrolithiasis	4.24e-05	0.000356	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	4.22e-05	0.000355	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GRHPR—nephrolithiasis	4.15e-05	0.000349	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GRHPR—nephrolithiasis	4.12e-05	0.000346	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PTH—nephrolithiasis	4.09e-05	0.000344	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	4.08e-05	0.000343	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	4.04e-05	0.00034	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	4.03e-05	0.000339	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AGXT—nephrolithiasis	4.02e-05	0.000338	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.02e-05	0.000338	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—DGKH—nephrolithiasis	4.02e-05	0.000338	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.96e-05	0.000332	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	3.96e-05	0.000332	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.95e-05	0.000332	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DGKH—nephrolithiasis	3.95e-05	0.000332	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.93e-05	0.000331	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	3.93e-05	0.000331	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AGXT—nephrolithiasis	3.93e-05	0.00033	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.92e-05	0.00033	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	3.92e-05	0.00033	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	3.88e-05	0.000326	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.88e-05	0.000326	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.87e-05	0.000326	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	3.87e-05	0.000326	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PTH—nephrolithiasis	3.86e-05	0.000324	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CHRM3—nephrolithiasis	3.83e-05	0.000322	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	3.8e-05	0.000319	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AQP1—nephrolithiasis	3.75e-05	0.000315	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PTH—nephrolithiasis	3.73e-05	0.000314	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AGXT—nephrolithiasis	3.7e-05	0.000311	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PTH—nephrolithiasis	3.69e-05	0.000311	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AGXT—nephrolithiasis	3.67e-05	0.000308	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	3.6e-05	0.000302	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.6e-05	0.000302	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GRHPR—nephrolithiasis	3.52e-05	0.000296	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	3.47e-05	0.000292	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—SPP1—nephrolithiasis	3.45e-05	0.00029	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AQP1—nephrolithiasis	3.44e-05	0.000289	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	3.43e-05	0.000288	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	3.42e-05	0.000288	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APRT—nephrolithiasis	3.42e-05	0.000288	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APRT—nephrolithiasis	3.34e-05	0.000281	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	3.34e-05	0.000281	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	3.31e-05	0.000278	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	3.29e-05	0.000277	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	3.2e-05	0.000269	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	3.15e-05	0.000265	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APRT—nephrolithiasis	3.15e-05	0.000264	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	3.15e-05	0.000264	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	3.14e-05	0.000264	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGXT—nephrolithiasis	3.13e-05	0.000264	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APRT—nephrolithiasis	3.12e-05	0.000262	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	3.12e-05	0.000262	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CHRM3—nephrolithiasis	3.11e-05	0.000262	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PTH—nephrolithiasis	3.03e-05	0.000254	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PTH—nephrolithiasis	3.01e-05	0.000253	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	2.93e-05	0.000246	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	2.91e-05	0.000244	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	2.88e-05	0.000242	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	2.86e-05	0.00024	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	2.85e-05	0.00024	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	2.84e-05	0.000239	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	2.81e-05	0.000236	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	2.8e-05	0.000235	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.71e-05	0.000228	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—SPP1—nephrolithiasis	2.68e-05	0.000225	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	2.67e-05	0.000224	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APRT—nephrolithiasis	2.67e-05	0.000224	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTH—nephrolithiasis	2.66e-05	0.000223	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTH—nephrolithiasis	2.62e-05	0.00022	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTH—nephrolithiasis	2.61e-05	0.000219	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	2.6e-05	0.000219	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTH—nephrolithiasis	2.6e-05	0.000219	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTH—nephrolithiasis	2.59e-05	0.000218	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTH—nephrolithiasis	2.57e-05	0.000216	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	2.56e-05	0.000215	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AQP1—nephrolithiasis	2.44e-05	0.000205	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.42e-05	0.000203	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	2.38e-05	0.0002	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AQP1—nephrolithiasis	2.38e-05	0.0002	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AQP1—nephrolithiasis	2.24e-05	0.000188	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AQP1—nephrolithiasis	2.22e-05	0.000187	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CHRM3—nephrolithiasis	2.2e-05	0.000185	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CHRM3—nephrolithiasis	2.15e-05	0.000181	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	2.06e-05	0.000173	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APRT—nephrolithiasis	2.06e-05	0.000173	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—SPP1—nephrolithiasis	2.05e-05	0.000173	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CHRM3—nephrolithiasis	2.03e-05	0.00017	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CHRM3—nephrolithiasis	2.01e-05	0.000169	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	1.94e-05	0.000163	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AQP1—nephrolithiasis	1.9e-05	0.00016	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	1.87e-05	0.000158	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	1.85e-05	0.000156	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	1.74e-05	0.000147	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CHRM3—nephrolithiasis	1.72e-05	0.000144	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	1.57e-05	0.000132	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	1.52e-05	0.000128	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	1.51e-05	0.000127	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	1.47e-05	0.000124	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.47e-05	0.000123	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	1.45e-05	0.000122	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SPP1—nephrolithiasis	1.33e-05	0.000112	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.33e-05	0.000111	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	1.31e-05	0.00011	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.31e-05	0.00011	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.31e-05	0.00011	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.3e-05	0.000109	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.29e-05	0.000108	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	1.29e-05	0.000108	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	1.19e-05	0.0001	CbGpPWpGaD
